Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
Background Balloon angioplasty with drug‐coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in‐stent restenosis. Despite its frequent use, there is a lack of long‐term data on the efficacy of DCB angioplasty. We conducted an investigation on the long‐term efficac...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.036839 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850060098461761536 |
|---|---|
| author | Sacharias von Koch Mikael Zhou Hans Christian Rosén Sammy Zwackman Juliane Jurga Per Grimfjärd Matthias Götberg Moman A. Mohammad David Erlinge |
| author_facet | Sacharias von Koch Mikael Zhou Hans Christian Rosén Sammy Zwackman Juliane Jurga Per Grimfjärd Matthias Götberg Moman A. Mohammad David Erlinge |
| author_sort | Sacharias von Koch |
| collection | DOAJ |
| description | Background Balloon angioplasty with drug‐coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in‐stent restenosis. Despite its frequent use, there is a lack of long‐term data on the efficacy of DCB angioplasty. We conducted an investigation on the long‐term efficacy outcome of in‐stent restenosis, comparing DCBs, drug‐eluting stents, and plain old balloon angioplasty. Methods and Results We conducted a nationwide analysis from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) including in‐stent restenosis lesions undergoing coronary angiography between June 11, 2013, and January 14, 2022. The primary outcome of this study was target‐lesion revascularization within a 5‐year follow‐up. Secondary outcomes included all‐cause death, cardiovascular death, myocardial infarction, and any percutaneous coronary intervention. The outcomes were analyzed using a multivariable Cox proportional hazard model or Poisson regression, as appropriate. A total of 10 561 lesions from 9062 patients were included. Compared with plain old balloon angioplasty, the use of DCB angioplasty was associated with less target‐lesion revascularization (risk ratio, 0.69 [95% CI, 0.57–0.82]), all‐cause death (risk ratio, 0.72 [95% CI, 0.59–0.88]), and cardiovascular death (hazard ratio [HR], 0.59 [95% CI, 0.45–0.78]). No difference was observed for myocardial infarction or any percutaneous coronary intervention. Compared with drug‐eluting stents, the use of DCBs was associated with higher rates of target‐lesion revascularization (HR, 1.20 [95% CI, 1.06–1.37]). No difference was observed for all‐cause death, cardiovascular death, myocardial infarction, or any percutaneous coronary intervention. Conclusions In this long‐term nationwide analysis, the use of DCB angioplasty showed superior outcomes compared with plain old balloon angioplasty within 5 years but higher rates of repeat revascularizations compared with drug‐eluting stents. |
| format | Article |
| id | doaj-art-6bc482fc910c4b388a6eb7acd94c401e |
| institution | DOAJ |
| issn | 2047-9980 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| spelling | doaj-art-6bc482fc910c4b388a6eb7acd94c401e2025-08-20T02:50:41ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802024-12-01132310.1161/JAHA.124.036839Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis StudySacharias von Koch0Mikael Zhou1Hans Christian Rosén2Sammy Zwackman3Juliane Jurga4Per Grimfjärd5Matthias Götberg6Moman A. Mohammad7David Erlinge8Department of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund SwedenDepartment of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund SwedenDepartment of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund SwedenDepartment of Health, Medicine and Caring Sciences and Department of Cardiology Linköping University Linköping SwedenDivision of Cardiology, Department of Medicine Karolinska Institute and Karolinska University Hospital Stockholm SwedenDepartment of Internal Medicine Västmanlands Hospital Västerås SwedenDepartment of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund SwedenDepartment of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund SwedenDepartment of Cardiology, Clinical Sciences Lund University, Skåne University Hospital Lund SwedenBackground Balloon angioplasty with drug‐coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in‐stent restenosis. Despite its frequent use, there is a lack of long‐term data on the efficacy of DCB angioplasty. We conducted an investigation on the long‐term efficacy outcome of in‐stent restenosis, comparing DCBs, drug‐eluting stents, and plain old balloon angioplasty. Methods and Results We conducted a nationwide analysis from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) including in‐stent restenosis lesions undergoing coronary angiography between June 11, 2013, and January 14, 2022. The primary outcome of this study was target‐lesion revascularization within a 5‐year follow‐up. Secondary outcomes included all‐cause death, cardiovascular death, myocardial infarction, and any percutaneous coronary intervention. The outcomes were analyzed using a multivariable Cox proportional hazard model or Poisson regression, as appropriate. A total of 10 561 lesions from 9062 patients were included. Compared with plain old balloon angioplasty, the use of DCB angioplasty was associated with less target‐lesion revascularization (risk ratio, 0.69 [95% CI, 0.57–0.82]), all‐cause death (risk ratio, 0.72 [95% CI, 0.59–0.88]), and cardiovascular death (hazard ratio [HR], 0.59 [95% CI, 0.45–0.78]). No difference was observed for myocardial infarction or any percutaneous coronary intervention. Compared with drug‐eluting stents, the use of DCBs was associated with higher rates of target‐lesion revascularization (HR, 1.20 [95% CI, 1.06–1.37]). No difference was observed for all‐cause death, cardiovascular death, myocardial infarction, or any percutaneous coronary intervention. Conclusions In this long‐term nationwide analysis, the use of DCB angioplasty showed superior outcomes compared with plain old balloon angioplasty within 5 years but higher rates of repeat revascularizations compared with drug‐eluting stents.https://www.ahajournals.org/doi/10.1161/JAHA.124.036839drug‐coated balloondrug‐eluting stentin‐stent restenosisplain old balloon angioplastytarget‐lesion revascularization |
| spellingShingle | Sacharias von Koch Mikael Zhou Hans Christian Rosén Sammy Zwackman Juliane Jurga Per Grimfjärd Matthias Götberg Moman A. Mohammad David Erlinge Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease drug‐coated balloon drug‐eluting stent in‐stent restenosis plain old balloon angioplasty target‐lesion revascularization |
| title | Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study |
| title_full | Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study |
| title_fullStr | Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study |
| title_full_unstemmed | Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study |
| title_short | Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study |
| title_sort | drug coated balloons versus drug eluting stents or plain old balloon angioplasty a long term in stent restenosis study |
| topic | drug‐coated balloon drug‐eluting stent in‐stent restenosis plain old balloon angioplasty target‐lesion revascularization |
| url | https://www.ahajournals.org/doi/10.1161/JAHA.124.036839 |
| work_keys_str_mv | AT sachariasvonkoch drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT mikaelzhou drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT hanschristianrosen drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT sammyzwackman drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT julianejurga drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT pergrimfjard drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT matthiasgotberg drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT momanamohammad drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy AT daviderlinge drugcoatedballoonsversusdrugelutingstentsorplainoldballoonangioplastyalongterminstentrestenosisstudy |